Rich Pharmaceuticals, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2338e55d-8ccb-4329-b99b-e8a031cff778/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-1.3M | 2017-04-01 – 2018-03-31 | evidence 0001662252-18-000076 |
| FY 2016 | $-951.8k | 2016-04-01 – 2017-03-31 | evidence 0001662252-17-000182 |
| FY 2015 | $-1.1k | 2015-04-01 – 2016-03-31 | evidence 0001662252-17-000182 |
| FY 2014 | $-3.6M | 2014-04-01 – 2015-03-31 | evidence 0001647488-15-000107 |
| FY 2013 | $-3.1M | 2010-08-09 – 2014-03-31 | evidence 0001255294-14-000711 |
| FY 2012 | $-31.4k | 2012-04-01 – 2013-03-31 | evidence 0001255294-13-000495 |
| FY 2011 | $-31.9k | 2011-04-01 – 2012-03-31 | evidence 0001255294-12-000474 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Rich Pharmaceuticals, Inc. — all facts · Revenue · Net Income